Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neuroectodermal Tumors, Primitive × surufatinib × 1 year × Clear all

Sponsor

Conditions

Pancreatic Neoplasms 5 Neuroendocrine Tumors 5 Small Cell Lung Carcinoma 3 Neoplasm Metastasis 2 Thyroid Carcinoma, Anaplastic 1 Stomach Neoplasms 1 Sarcoma 1 Pulmonary Neuroendocrine Tumor 1 Pancreatic cancer, adult 1 Pancreatic Cancer Metastatic 1 Ovarian Neoplasms 1 Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Appendiceal Neoplasms 1

Interventions

Cyclophosphamide 6 Vincristine 3 Temozolomide 3 Radiotherapy 3 Cisplatin 3 Automobiles 3 fludarabine 2 Etoposide 2 Eflornithine 2 Carboplatin 2 omburtamab I-131 1 ibrutinib 1 gallium Ga 68 dotatate 1 etoposide phosphate 1 belzutifan 1 Zoledronic Acid 1 Thiotepa 1 Tamoxifen 1 Standard of Care 1 Radiotherapy, Image-Guided 1 Pemetrexed 1 ONC206 1 Nivolumab 1 Mesna 1 Maintenance Chemotherapy 1 Lomustine 1 Isotretinoin 1 Infusions, Intravenous 1 Induction Chemotherapy 1 Hydrocortisone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡